Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S
Explore the PTAB proceeding IPR2023-00724 filed by Mylan Pharmaceuticals Inc. et al. on 2023-03-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-00724
Filing Date
2023-03-16
Accorded Filing Date
2023-03-16
Institution Decision Date
2023-10-04
Last Modified Date
2025-03-07
Proceeding Type
IPR
Termination Date
2025-01-10
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
White, Brandonet alPatent Owner / Respondent
Novo Nordisk A/S
Represented By
Baughman, Jonet alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Respondent Application Number
15656042
Respondent Patent Number
10335462
External Links
Respondent Inventor
Christine Bjoern Jensen
Respondent Tech Center
TC 1600 - Biotechnology & Organic Chemistry
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Firm
/ Entity Name
NOVO NORDISK INC. - INTELLECTUAL PROPERTY DEPARTMENT
Customer
Number
23650
Address
800 Scudders Mill Road, Plainsboro, NJ, 08536, UNITED STATES
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 56129 | Wesley Nicolas | 609-786-5418 |
| 62124 | Leon Lum | 609-786-4172 |
| 63996 | Elizabeth Dingess-Hammond | 317-433-3689 |
| 64519 | Jianjie Hu | 609-786-4129 |
| 74995 | Kathryn Jones | 804-426-7196 |
Proceeding Documents
200
122
Order: Granting PO's Motion to Expunge ORDER
2025-03-07
FILING PARTY: BOARD
121
Patent Owner's Motion to Expunge OTHER
2025-02-11
FILING PARTY: PATENT OWNER
118
Termination Decision: Post-DI Settlement TERMINATE
2025-01-10
FILING PARTY: BOARD
119
Order: Order on Motions to Expunge ORDER
2025-01-10
FILING PARTY: BOARD
120
Order: On Protective Orders and Motions to Seal ORDER
2025-01-10
FILING PARTY: BOARD